STYLAGE XXL BI-SOFT

Introduced to the UK in approximately 2011 and manufactured by the French company Vivacy Laboratories, Stylage® is the first hyaluronic acid dermal filler with local anaesthetic lidocaine (lignocaine) and an antioxidant, in the form of mannitol, all within one product. The presence of mannitol, the "free radical scavenger", limits the devastating effects of free radicals on the dermis and product injected, thus reducing the risk of post-injection inflammation and preventing the gel's structure degradation.

With their patented IPN-like® Technology (Interpenetrated Network), Vivacy has created something which has two structures—the monophasic A and B structure, and the IPN-like structure. The two are mechanically independent, so Stylage is easy to inject and the increased density of its cross-linking nodes make it long-lasting. This methods requires less BDDE (a common compound used in cross linking hyauronic acids) which the company claims is more effective and results in a safer, longer lasting product.

Stylage® XXL is the most cohesive and most volumizing of the STYLAGE® product line. It is easily injected with a cannula and remains easy to model, thereby ensuring effective and very natural correction. Stylage® XXL can give skin the tightness it needs to eliminate all signs of sagging and hollowness. Using hyaluronic acid based gel sterile, formulated from an animal free and biocompatible hyaluronan serum that magically lifts even the deepest of wrinkles away from around the mouth.

The duration of the effect of a Stylage® XXL treatment is 12 months. It's very individual and depends on many factors, such as the patient's skin type and structure, age, lifestyle, the area treated and the injection technique used by the practitioner.

INDICATIONS

Stylage® XXL is injection into deep dermis or the subcutaneous (SQ) layers of skin

• treatment of facial volume defects,
• restoration of facial contours (cheekbones, cheeks, chin),
• cheekbone area augmentation,
• treatment of slight ptosis,
• correction of deep skin depressions.

COMPOSITION

Cross-linked hyaluronic acid IPN-Like: 21 mg/g

Lidocaine: -

Mannitol q.s. 1g

Phosphate buffer pH: 7,2

PACKAGE

2 x 1 ml prefilled syringe

needles: 2 x 27G 1/2, 2 x 25G 40

CONTRAINDICATED

• hypersensitivity to one of the components,
• skin infection near the site of injection,
• patients susceptible to keloid formation,
• pregnant or lactating women,
• allergy or anaphylaxis,
• bleeding disorders,
• autoimmune disorders,
• antibiotic therapy.

Product for professional use only. By deciding to purchase, you declare that you are a doctor or cosmetologist trained in aesthetic medicine.

Read the package leaflet before use.